Regulación y derecho · 2/9/20151 min de lectura
Prospective Grant of Co-Exclusive License: Biomarkers for Acute Ischemic Stroke
Traducción automática local · Idioma original de la fuente
Resumen
This is notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a co-exclusive patent license to practice the inventions embodied in U.S. Patent Application No. 13/580,571 filed 22 August, 2012 and entitled "Biomarkers for Acute Ischemic Stroke" [HHS Ref. No. E-023-2010/0-US-03] to CereDx, Inc., which is located in West Virginia. The patent rights in this invention have been assigned to the United States of America. The prospective co-exclusive license territory may be worldwide and the field of use may be limited to the use of the diagnostics of ischemic stroke.